{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:14:57Z","timestamp":1792250097656,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.dmd.2025.100130","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T15:10:09Z","timestamp":1753283409000},"page":"100130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A primary human Gut\/Liver microphysiological system to estimate human oral bioavailability"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8052-6691","authenticated-orcid":false,"given":"Yassen","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4720-1603","authenticated-orcid":false,"given":"Morn\u00e9","family":"van Wyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey","family":"Sze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Christophi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Spreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1153-090X","authenticated-orcid":false,"given":"Robert Jarrett","family":"Bliton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0368-2572","authenticated-orcid":false,"given":"Elizabeth M.","family":"Boazak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6309-628X","authenticated-orcid":false,"given":"Tomasz","family":"Kostrzewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmd.2025.100130_bib1","first-page":"1","article-title":"Drug Bioavailability","author":"Price","year":"2023","journal-title":"xPharm: The Comprehensive Pharmacology Reference"},{"key":"10.1016\/j.dmd.2025.100130_bib2","article-title":"Best practices in current models mimicking drug permeability in the gastrointestinal tract \u2013 an UNGAP review","volume":"170","author":"O\u2019Shea","year":"2022","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.dmd.2025.100130_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40262-015-0351-6","article-title":"Predicting drug extraction in the human gut wall: assessing contributions from drug metabolizing enzymes and transporter proteins using preclinical models","volume":"55","author":"Peters","year":"2016","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.dmd.2025.100130_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1208\/s12248-016-9889-y","article-title":"Gut wall metabolism. Application of pre-clinical models for the prediction of human drug absorption and first-pass elimination","volume":"18","author":"Jones","year":"2016","journal-title":"AAPS J"},{"issue":"100","key":"10.1016\/j.dmd.2025.100130_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejps.2013.08.018","article-title":"Animal versus human oral drug bioavailability: do they correlate?","volume":"57","author":"Musther","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1016\/j.dmd.2025.100130_bib6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.12793\/tcp.2020.28.e14","article-title":"Predicting human pharmacokinetics from preclinical data: absorption","volume":"28","author":"Yim","year":"2020","journal-title":"Transl Clin Pharmacol"},{"key":"10.1016\/j.dmd.2025.100130_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2023.100497","article-title":"Generation of Caco-2 cells with predictable metabolism by CYP3A4, UGT1A1 and CES using the PITCh system","volume":"50","author":"Yamada","year":"2023","journal-title":"Drug Metab Pharmacokinet"},{"issue":"7","key":"10.1016\/j.dmd.2025.100130_bib8","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1124\/dmd.110.032649","article-title":"Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data","volume":"38","author":"Gertz","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.dmd.2025.100130_bib9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1124\/dmd.120.000111","article-title":"Evaluation of in vitro models for assessment of human intestinal metabolism in drug discovery","volume":"48","author":"Davies","year":"2020","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2025.100130_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/bdd.2062","article-title":"Quantifying gut wall metabolism: methodology matters","volume":"38","author":"Hatley","year":"2017","journal-title":"Biopharm Drug Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2025.100130_bib11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1208\/s12248-014-9691-7","article-title":"Addressing the challenges of low clearance in drug research","volume":"17","author":"Di","year":"2015","journal-title":"AAPS J"},{"issue":"9","key":"10.1016\/j.dmd.2025.100130_bib12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1535370214542068","article-title":"The relevance and potential roles of microphysiological systems in biology and medicine","volume":"239","author":"Wikswo","year":"2014","journal-title":"Exp Biol Med (Maywood)"},{"issue":"6561","key":"10.1016\/j.dmd.2025.100130_bib13","first-page":"1304","article-title":"Human microphysiological systems for drug development","volume":"373","author":"Roth","year":"2021","journal-title":"Science (1979)"},{"issue":"3","key":"10.1016\/j.dmd.2025.100130_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1039\/C9LC00857H","article-title":"Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization","volume":"20","author":"Fowler","year":"2020","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.dmd.2025.100130_bib15","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1038\/s41598-018-22749-0","article-title":"Interconnected microphysiological systems for quantitative biology and pharmacology studies","volume":"8","author":"Edington","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.dmd.2025.100130_bib16","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1208\/s12248-017-0122-4","article-title":"Integrated gut and liver microphysiological systems for quantitative in vitro pharmacokinetic studies","volume":"19","author":"Tsamandouras","year":"2017","journal-title":"AAPS J"},{"issue":"15","key":"10.1016\/j.dmd.2025.100130_bib17","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1039\/D2LC00276K","article-title":"Application of a gut\u2013liver-on-a-chip device and mechanistic modelling to the quantitative in vitro pharmacokinetic study of mycophenolate mofetil","volume":"22","author":"Milani","year":"2022","journal-title":"Lab Chip"},{"key":"10.1016\/j.dmd.2025.100130_bib18","article-title":"Lmfit: non-linear least-square minimization and curve-fitting for python","author":"Newville","year":"2016","journal-title":"Astrophysics Source Code Library"},{"key":"10.1016\/j.dmd.2025.100130_bib19","series-title":"lmfit\/lmfit-py: 1.3.2","author":"Newville","year":"2024"},{"issue":"6","key":"10.1016\/j.dmd.2025.100130_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Autom Contr"},{"key":"10.1016\/j.dmd.2025.100130_bib21","series-title":"emcee: the MCMC Hammer","author":"Foreman-Mackey","year":"2012"},{"issue":"10","key":"10.1016\/j.dmd.2025.100130_bib22","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1020483911355","article-title":"Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs","volume":"19","author":"Sun","year":"2002","journal-title":"Pharm Res"},{"issue":"7825","key":"10.1016\/j.dmd.2025.100130_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"Harris","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.dmd.2025.100130_bib24","series-title":"Proceedings of the 9th Python in Science Conference","doi-asserted-by":"crossref","first-page":"56","DOI":"10.25080\/Majora-92bf1922-00a","article-title":"Data Structures for Statistical Computing in Python","author":"McKinney","year":"2010"},{"issue":"3","key":"10.1016\/j.dmd.2025.100130_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat Methods"},{"issue":"3","key":"10.1016\/j.dmd.2025.100130_bib26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/cts.12969","article-title":"Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation","volume":"14","author":"Rubiano","year":"2021","journal-title":"Clin Transl Sci"},{"issue":"2","key":"10.1016\/j.dmd.2025.100130_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1039\/C9LC00768G","article-title":"Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry","volume":"20","author":"Baudy","year":"2020","journal-title":"Lab Chip"},{"issue":"8","key":"10.1016\/j.dmd.2025.100130_bib28","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3390\/ph15080975","article-title":"Intestinal absorption study: challenges and absorption enhancement strategies in improving oral drug delivery","volume":"15","author":"Azman","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.dmd.2025.100130_bib29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cell.2010.09.016","article-title":"Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells","volume":"143","author":"Snippert","year":"2010","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.dmd.2025.100130_bib30","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1124\/dmd.105.004226","article-title":"Identification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption","volume":"33","author":"Imai","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"1-2","key":"10.1016\/j.dmd.2025.100130_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.chroma.2003.12.039","article-title":"Determination of midazolam and its metabolite as a probe for cytochrome P450 3A4 phenotype by liquid chromatography\u2013mass spectrometry","volume":"1031","author":"Kanazawa","year":"2004","journal-title":"J Chromatogr A"},{"issue":"7","key":"10.1016\/j.dmd.2025.100130_bib32","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1517\/17425255.4.7.909","article-title":"Potential role of intestinal first-pass metabolism in the prediction of drug\u2013drug interactions","volume":"4","author":"Galetin","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"Suppl 1","key":"10.1016\/j.dmd.2025.100130_bib33","first-page":"43S","article-title":"Pharmacokinetics and bioavailability of midazolam in man","volume":"16 Suppl 1","author":"Heizmann","year":"1983","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100130_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00562804","article-title":"The pharmacokinetics of midazolam in man","volume":"19","author":"Smith","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.dmd.2025.100130_bib35","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/psp4.13192","article-title":"Combining data on the bioavailability of midazolam and physiologically-based pharmacokinetic modeling to investigate intestinal CYP3A4 ontogeny","volume":"13","author":"Johnson","year":"2024","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"7875","key":"10.1016\/j.dmd.2025.100130_bib36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41586-021-03852-1","article-title":"Cells of the human intestinal tract mapped across space and time","volume":"597","author":"Elmentaite","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.dmd.2025.100130_bib37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/A:1023433502647","article-title":"Midazolam exhibits characteristics of a highly permeable P-glycoprotein substrate","volume":"20","author":"Tolle-Sander","year":"2003","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.dmd.2025.100130_bib38","first-page":"14","article-title":"First-pass metabolism of midazolam by the human intestine","volume":"60","author":"Paine","year":"1996","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.dmd.2025.100130_bib39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2174\/138920007782109733","article-title":"Prediction of intestinal first-pass drug metabolism","volume":"8","author":"Yang","year":"2007","journal-title":"Curr Drug Metab"},{"issue":"8","key":"10.1016\/j.dmd.2025.100130_bib40","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2174\/138920008786049276","article-title":"Grapefruit juice-drug interaction studies as a method to assess the extent of intestinal availability: utility and limitations","volume":"9","author":"Gertz","year":"2008","journal-title":"Curr Drug Metab"},{"issue":"5","key":"10.1016\/j.dmd.2025.100130_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1124\/dmd.115.068601","article-title":"Mechanistic modeling to predict midazolam metabolite exposure from in vitro data","volume":"44","author":"Nguyen","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmd.2025.100130_bib42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1039\/C6IB00243A","article-title":"Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS)","volume":"9","author":"Maass","year":"2017","journal-title":"Integr Biol (Camb)"},{"issue":"6","key":"10.1016\/j.dmd.2025.100130_bib43","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1039\/D1LC01161H","article-title":"Exploration and application of a liver-on-a-chip device in combination with modelling and simulation for quantitative drug metabolism studies","volume":"22","author":"Docci","year":"2022","journal-title":"Lab Chip"},{"issue":"10","key":"10.1016\/j.dmd.2025.100130_bib44","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0169-409X(02)00066-2","article-title":"Genetic contribution to variable human CYP3A-mediated metabolism","volume":"54","author":"Lamba","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.dmd.2025.100130_bib45","series-title":"Roadmap to Reducing Animal Testing in Preclinical Safety Studies","year":"2025"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T07:41:33Z","timestamp":1758699693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625091391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0090955625091391"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100130","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A primary human Gut\/Liver microphysiological system to estimate human oral bioavailability","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100130"}}